| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc. | Happel David | President & CEO | Mar 26, 2024 | Buy | $5.27 | 12,100 | 63,731 | 639,200 | Mar 28, 2024, 04:08 PM | |
| SGMT | Sagimet Biosciences Inc. | Happel David | President & CEO | Dec 07, 2023 | Buy | $4.10 | 1,600 | 6,560 | 627,100 | Dec 08, 2023, 04:05 PM | |
| SGMT | Sagimet Biosciences Inc. | Happel David | President & CEO | Nov 16, 2023 | Buy | $2.35 | 590 | 1,386 | 590 | Nov 20, 2023, 09:59 PM | |
| HZNP | Horizon Pharma plc | Happel David | EVP, Commercial Dev & Strategy | Oct 25, 2017 | Option Exercise | $13.53 | 4,150 | 56,149 | 5,089 | Oct 26, 2017, 07:39 PM | |
| RPTP | Raptor Pharmaceutical Corp | Happel David | Chief Commercial Officer | Oct 24, 2016 | Option Exercise | $9.00 | 8,934 | 80,406 | 28,939 | Oct 26, 2016, 04:41 PM | |
| RPTP | Raptor Pharmaceutical Corp | Happel David | Chief Commercial Officer | Oct 25, 2016 | Option Exercise | $9.00 | 28,939 | 260,451 | 0 | Oct 26, 2016, 04:41 PM | |
| RPTP | Raptor Pharmaceutical Corp | Happel David | Chief Commerical Officer | Mar 01, 2016 | Option Exercise | $3.43 | 576 | 1,977 | 29,670 | Mar 03, 2016, 07:23 PM |
Menu